Sulforaphene inhibits triple negative breast cancer through activating tumor suppressor Egr1.
about
Antitumor activity and expression profiles of genes induced by sulforaphane in human melanoma cells.Sulforaphene attenuates multinucleation of pre-osteoclasts by suppressing expression of cell-cell fusion-associated genes DC-STAMP, OC-STAMP, and Atp6v0d2.Dietary Natural Products for Prevention and Treatment of Breast Cancer.CHST9 rs1436904 genetic variant contributes to prognosis of triple-negative breast cancer.MiR-301b promotes the proliferation, mobility, and epithelial-to-mesenchymal transition of bladder cancer cells by targeting EGR1.Guide for Current Nutrigenetic, Nutrigenomic, and Nutriepigenetic Approaches for Precision Nutrition Involving the Prevention and Management of Chronic Diseases Associated with Obesity.
P2860
Sulforaphene inhibits triple negative breast cancer through activating tumor suppressor Egr1.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Sulforaphene inhibits triple n ...... ivating tumor suppressor Egr1.
@en
Sulforaphene inhibits triple n ...... ivating tumor suppressor Egr1.
@nl
type
label
Sulforaphene inhibits triple n ...... ivating tumor suppressor Egr1.
@en
Sulforaphene inhibits triple n ...... ivating tumor suppressor Egr1.
@nl
prefLabel
Sulforaphene inhibits triple n ...... ivating tumor suppressor Egr1.
@en
Sulforaphene inhibits triple n ...... ivating tumor suppressor Egr1.
@nl
P2093
P2860
P1476
Sulforaphene inhibits triple n ...... ivating tumor suppressor Egr1.
@en
P2093
P2860
P2888
P304
P356
10.1007/S10549-016-3888-7
P407
P577
2016-07-04T00:00:00Z